Clinical Trial Update: A Comparative Study of FV-100 vs. Valacyclovir for the Prevention of Post-Herpetic Neuralgia [Phase 3]

View source ↗

Summary

Phase 3 trial comparing FV-100 to Valacyclovir for preventing post-herpetic neuralgia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster
• Postherpetic Neuralgia
• Shingles

Drugs mentioned

• FV-100
• Valacyclovir (Valacyclovir)

Snippet

Sponsor: ContraVir Pharmaceuticals, Inc. | Conditions: Shingles, Herpes Zoster | Phase 3 | Status: TERMINATED